Navigation Links
Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
Date:3/17/2008

n (n=537), which includes patients randomized who did not enter the maintenance phase of the study. During the dosing period under analysis, there was no difference in the incidence of serious adverse events between treatment groups. Potentially drug-related serious adverse events occurred in 1% of placebo patients, 2% of patients in the 150mg dosing group, 0% of patients in the 300mg dosing group and 1% of patients in the 500mg dosing group. There were no cases of drug-related "Torsades de Pointes", a well-characterized arrhythmia which is an occasional side effect of some current anti-arrhythmic drugs. There were 2 deaths during this period, both unrelated to vernakalant (oral), comprising a patient in the 150mg dosing group who died of cervical cancer at day 79, and a patient in the placebo group who died at day 86 after suffering an ischemic stroke.

"Our strategic intent with this study was to pave the way to Phase 3 and provide efficacy and safety data to support business discussions," said Bob Rieder, Chairman and Chief Executive Officer of Cardiome. "This strong interim data set clearly enables us to move forward in planning the Phase 3 program and continue our discussions with interested parties."

The double-blind, placebo-controlled, randomized, dose-ranging study was designed to explore safety and tolerability, pharmacokinetics and efficacy of vernakalant (oral) over 90 days of dosing in patients at risk of recurrent atrial fibrillation. Patients received a 150mg, 300mg or 500mg dose of vernakalant (oral) or placebo twice per day. After the first 3 days, patients still in atrial fibrillation were electrically cardioverted. Successfully cardioverted patients continued to receive vernakalant (oral) or placebo for the remainder of the 90-day trial and were monitored throughout the dosing period.

Cardiome initiated the Phase 2b in the first quarter of 2007. Enrollment has completed, with a total of 735 patients randomized of which approxim
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. Cardiome to Hold Investor Update Call
3. Cardiome Updates Guidance
4. Cardiome Initiates Phase 1 Study for GED-aPC
5. Cardiome To Release Third Quarter Results
6. Cardiome to Present at CIBC Conference
7. Cardiome to Present at ThinkEquity Conference
8. Cardiome to Present at Bear Stearns Conference
9. Weight Watchers Announces Election of Kim Roy to Board of Directors
10. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
11. Exelixis Announces March 19 Webcast of Presentation at the Lehman Brothers Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... AWeber, one of the leading ... helps more than 120,000 small businesses across the globe ... Shane Michaels, prompting an investigative review. , “Email ... online marketing campaign, despite what some people might think ... reports Michaels. “AWeber is a great solution for entrepreneurs, ...
(Date:8/22/2014)... This report studies the "Sample Preparation Market by ... Kits (Isolation, Purification), By Application (Genomics, Proteomics), by ... 2018" This market was valued at $4,254.8 million ... a CAGR of 5.9% from 2013 to 2018, ... 98 market data Tables and 23 Figures spread ...
(Date:8/22/2014)... 2014 Millennium Treatment Group has recently noticed ... high level of drug use among teenagers. The treatment facility ... addiction and work to minimize drug abuse. , America is ... drug addiction in history. According to the National Institute ... Americans aged 12 or older—or 9.2 percent of the population—had ...
(Date:8/22/2014)... A Penn Medicine team has found that targeted ... urinary tract infections in hospital patients with urinary ... alert was simplified, the rate of improvement dramatically ... their patients need urinary catheters in the first ... need for catheters that have not been removed ...
(Date:8/22/2014)... Lake Worth, FL (PRWEB) August 22, 2014 ... alcohol addiction treatment facility in Lantana, FL, recently ... or those just looking for information can now ... , Millennium’s new website just went live at ... to know about the facility can be found ...
Breaking Medicine News(10 mins):Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Millennium Treatment Group Has a New Website 2
... , , SEATTLE, July 29 ... that it was notified by the European Medicines Agency ("EMEA") that ... ("MAA") through the EMEA,s centralized procedure. The centralized review process provides ... is conducted by the EMEA on behalf of all European Union ...
... , , , ... called Indiana Drug Card, is being launched today. The program, which ... pharmacy discounts on prescription drugs. This program has no restrictions on ... applications to fill out. Indiana Drug Card is accepted at over ...
... risk rises 75 percent when device use begins before age ... -- The International Agency for Research on Cancer on Tuesday ... "carcinogenic to humans," according to a new report. , Previously, ... carcinogenic, so the move puts the devices a notch higher ...
... Finding time to treat the "you" in yourself is important to maintaining ... how you can do just that with the right simple snack. , ... , http://inr.mediaseed.tv/oneClip_C/?feed=LRP2yXtJhkA_O5oRbn5PG4L4KgGq7sMi , , ... free and unrestricted use at http://www.mediaseed.tv . ...
... NEW YORK, JULY 28 The American Society of ... the 2009 updated Interventional Pain Management (IPM) guidelines. , ... stated that, "The purpose of the IPM guidelines is to ... chronic or persistent pain, and provide information about the scientific ...
... , DETROIT, July 28 Caraco ... sales of $48.1 million in the first quarter of Fiscal 2010, ... period of Fiscal 2009. The reduction in sales was primarily due ... as compared to the corresponding period of Fiscal 2009. Sales of ...
Cached Medicine News:Health News:Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe 2Health News:Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe 3Health News:Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe 4Health News:Indiana Drug Card to Provide Free Drug Cards to Residents 2Health News:Tanning Beds Get Highest Carcinogen Rating 2Health News:Tanning Beds Get Highest Carcinogen Rating 3Health News:New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 2Health News:New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010 5Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010 6Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010 7
(Date:8/22/2014)... , Aug. 22, 2014 Today, the ... modify the religious "accommodation" but still require religious ... have an abortifacient effect, including Plan B (the ... pill"). The Obama Administration also announced that it ... held, for-profit corporations. The regulations issued ...
(Date:8/22/2014)... 22, 2014 /CNW/ - On Aug. 20, at its ... Canadian Medical Association (CMA) voted on and approved a ... including medicinal cannabis. Bedrocan Cannabis Corp., a leading Canadian ... CMA motion. The CMA is quite right ... with smoking any plant material, including medicinal cannabis. While ...
(Date:8/22/2014)... MC Medical, a subsidiary of Mitsubishi Corporation (MCM), and Minimally ... medical device company, have formally agreed to an exclusive ... in Japan . It is anticipated that ... in the latter half of 2015. ... in endoscopic surgery market in Japan . ...
Breaking Medicine Technology:Liberty Institute: Government "Accommodation" Still Requires Employers To Facilitate Coverage Of Abortifacient Drugs 2Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2
... 10, 2011 Sildenafil, a drug used to ... possible use -- helping children and young adults ... Sildenafil significantly improved measures of exercise performance during ... according to researchers from The Children,s Hospital of ...
... seek ways to reduce Medicaid spending, they should start by ... model to the more efficient model used in some parts ... finds that the program could save $473 million over ... more like those in Medicare and commercial plans. Governors Chris ...
Cached Medicine Technology:Exercise Performance in Children and Young Adults with Single Ventricle Heart Disease Improves with Use of Drug for Erectile Dysfunction 2Exercise Performance in Children and Young Adults with Single Ventricle Heart Disease Improves with Use of Drug for Erectile Dysfunction 3Budget Solution? Modernizing Medicaid Pharmacy Could Save Florida $473 Million 2
Steroid-eluting, epicardial pacing leads...
... is one of the world's ... with a 7 F introducer, ... is designed to lower the ... allow introduction in smaller, more ...
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
Medicine Products: